Rolf Anton Klaasen

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases

Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Guro Løvik Goll et al. · JAMA · 2021 · 160 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss

C A Wijbrandts, Rolf Anton Klaasen, M.G.W. Dijkgraaf et al. · Annals of the Rheumatic Diseases · 2008 · 148 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial

Guro Løvik Goll, Kristin Kaasen Jørgensen, J. Sexton et al. · Journal of Internal Medicine · 2019 · 122 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases

Silje Watterdal Syversen, Guro Løvik Goll, Kristin Kaasen Jørgensen et al. · JAMA · 2021 · 121 citations · Full text

Medicine, Immunology, Pharmacology +17

High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation

Erlend Johannessen Egeland, Ida Robertsen, Monica Hermann et al. · Transplantation · 2017 · 48 citations · Full text

Pharmacy, Nephrology, Pharmacokinetics +17